<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT201108157334N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2012-10-08</date_registration>
      <primary_sponsor>Vice chancellor for research of Tehran University of Medical Sciences</primary_sponsor>
      <public_title>Efficacy of Isosorbide dinitrate in cervical ripening</public_title>
      <acronym></acronym>
      <scientific_title>A comparision of out patient oral and vaginal  Isosorbide dinitrate in cervical ripening befor induction of labor in post term pregnancy with low bishop score</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2012-03-19</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>150</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/7780</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Double blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment.</study_design>
      <phase>N/A</phase>
      <hc_freetext>Isosorbide dinitrate effect on cervical ripening.</hc_freetext>
      <i_freetext>Intervention 1: Samples of investigation are divided into three groups based on randomly numbers table., in one group  isosorbide dinitrate 40 mg should be placed vaginaly in  posterior fornix.The Bishop score is determined at the beginning of the study. After taking medication, the patients will be under observe for 4 hours and then discharged and advised to return 24 hours later for assessing Bishop score and induction of labor.THE induction starts with2.5mIU/min of  10 unit oxitocin in 1000 ml Ringer lactate and every fifteen minutes 2.5mIU/min will be added . With adequate contractions, induction to delivery time is measured.  If adequate contractions is not induced with max 40 mIU/min oxytocin,labor induction is stopped  and the  patient returns to prenatal unit waiting for second induction in the next day .if bishop score with adequate contractions dont change after  12 hours, labor induction is stopped  and the  patient returns to prenatal unit waiting for second induction in the next day Also, if headache is occures after administration of ISDN, patient should be  given acetaminophen. . Intervention 2: Samples of investigation are divided into three groups based on randomly numbers table., in one group isosorbide dinitrate20 mg should be given oraly.The Bishop score is determined at the beginning of the study. After taking medication, the patients will be under observe for 4 hours and then discharged and advised to return 24 hours later for assessing Bishop score and induction of labor.THE induction starts with2.5mIU/min of 10 mg oxitocin in 1000 ml Ringer lactate and every fifteen minutes 2.5mIU/min will be added . With adequate contractions, induction to delivery time MEASURE. If adequate contractions is not induced with max 40 mIU/min oxytocin,labor induction is stopped and the patient returns to prenatal unit waiting for second induction in the next day .if bishop score with adequate contractions dont change after 12 hours, labor induction is stopped and the patient returns to prenatal unit waiting for second induction in the next day Also, if the headache is detect after administration of ISDN shuld given acetaminophen. . Intervention 3: Samples of investigation are divided into three groups based on randomly numbers tablethat one group is control.they dont take any drug.The Bishop score is determined at the beginning of the study.THE induction starts with2.5mIU/min of 10 mg oxitocin in 1000 ml Ringer lactate and every fifteen minutes 2.5mIU/min will be added . With adequate contractions, induction to delivery time is measured. If adequate contractions is not induced with max 40 mIU/min oxytocin,labor induction is stopped and the patient returns to prenatal unit waiting for second induction in the next day .if bishop score with adequate contractions dont change after 12 hours, labor induction is stopped and the patient returns to prenatal unit waiting for second induction in the next day.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan></results_IPD_plan>
      <results_IPD_description></results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Dr Ladan Haghighi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Enghelab street -tehran university</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip></zip>
        <telephone>+98 21 66111</telephone>
        <email>l-haghighi@sina.tums.ac.ir</email>
        <affiliation>Tehran University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Dr Ladan Haghighi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Enghelab street -Tehran university</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip></zip>
        <telephone>+98 21 66111</telephone>
        <email>l-haghighi@sina.tums.ac.ir</email>
        <affiliation>Tehran University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Inclusion criteria:&#13;
1)Nulliparity 2)Gestational age&gt;42 weeks 3)Bishop score&lt;5 4)Singleton pregnancy  5)Cephalic presentation 6) filled Consent form.&#13;
   Exclusion criteria:&#13;
 1)Premature rupture of membrane 2)Vaginal bleeding 3)Contraindication for ISDN   4)History of any uterian scar  5)Intolerance to ISDN 6)Any systemic disease 7)Laber pain 8)Oligohydramnios 9)IUGR 10)Non-reassuring FHR</inclusion_criteria>
      <agemin>10 years</agemin>
      <agemax>50 years</agemax>
      <gender>Female</gender>
      <exclusion_criteria></exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>P08</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Disorders related to long gestation and high birth weight</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Treatment - Drugs</i_code>
      <i_code>Treatment - Drugs</i_code>
      <i_code>Treatment - Drugs</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Samples of investigation are divided into three groups based on randomly numbers table., in one group  isosorbide dinitrate 40 mg should be placed vaginaly in  posterior fornix.The Bishop score is determined at the beginning of the study. After taking medication, the patients will be under observe for 4 hours and then discharged and advised to return 24 hours later for assessing Bishop score and induction of labor.THE induction starts with2.5mIU/min of  10 unit oxitocin in 1000 ml Ringer lactate and every fifteen minutes 2.5mIU/min will be added . With adequate contractions, induction to delivery time is measured.  If adequate contractions is not induced with max 40 mIU/min oxytocin,labor induction is stopped  and the  patient returns to prenatal unit waiting for second induction in the next day .if bishop score with adequate contractions dont change after  12 hours, labor induction is stopped  and the  patient returns to prenatal unit waiting for second induction in the next day Also, if headache is occures after administration of ISDN, patient should be  given acetaminophen. .</i_keyword>
      <i_keyword>Samples of investigation are divided into three groups based on randomly numbers table., in one group isosorbide dinitrate20 mg should be given oraly.The Bishop score is determined at the beginning of the study. After taking medication, the patients will be under observe for 4 hours and then discharged and advised to return 24 hours later for assessing Bishop score and induction of labor.THE induction starts with2.5mIU/min of 10 mg oxitocin in 1000 ml Ringer lactate and every fifteen minutes 2.5mIU/min will be added . With adequate contractions, induction to delivery time MEASURE. If adequate contractions is not induced with max 40 mIU/min oxytocin,labor induction is stopped and the patient returns to prenatal unit waiting for second induction in the next day .if bishop score with adequate contractions dont change after 12 hours, labor induction is stopped and the patient returns to prenatal unit waiting for second induction in the next day Also, if the headache is detect after administration of ISDN shuld given acetaminophen. .</i_keyword>
      <i_keyword>Samples of investigation are divided into three groups based on randomly numbers tablethat one group is control.they dont take any drug.The Bishop score is determined at the beginning of the study.THE induction starts with2.5mIU/min of 10 mg oxitocin in 1000 ml Ringer lactate and every fifteen minutes 2.5mIU/min will be added . With adequate contractions, induction to delivery time is measured. If adequate contractions is not induced with max 40 mIU/min oxytocin,labor induction is stopped and the patient returns to prenatal unit waiting for second induction in the next day .if bishop score with adequate contractions dont change after 12 hours, labor induction is stopped and the patient returns to prenatal unit waiting for second induction in the next day.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Cervical ripening. Timepoint: 24 hours. Method of measurement: Vaginal exam.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome>Time from full dilatation to delivery. Timepoint: Stage 2 of labor. Method of measurement: Minut.</sec_outcome>
      <sec_outcome>Time from active phase to full dilation. Timepoint: Stage 1 of labor. Method of measurement: Minut.</sec_outcome>
      <sec_outcome>From induction to active phase. Timepoint: active phase. Method of measurement: minut.</sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Vice chancellor for research of Tehran University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2012-01-16</approval_date>
        <contact_name>Tehran University of Medical Sciences Ethics Committee</contact_name>
        <contact_address>Tehran University of Medical Sciences, Enghelab st. Tehran  Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
